Des-gamma-carboxy prothrombin

There are 10 papers on des-gamma-carboxy prothrombin in aging research: 1 trial and 7 observational studies in people, 2 reviews.

Biomarker

10 papers study it1 finding

See all 10 papers on des-gamma-carboxy prothrombin

“a doubling of des-γ-carboxy prothrombin concentration was associated with a 1.53 (95% confidence interval, 1.09-2.13; P=0.008) higher risk of incident ischemic cardiovascular disease.”
Vitamin K-Dependent Protein Activity and Incident Ischemic Cardiovascular Disease: The Multi-Ethnic Study of AtherosclerosisArteriosclerosis, thrombosis, and vascular biology2016doi:10.1161/atvbaha.116.307273
  • Human trial1
  • Humans7

Associations

1

Incident ischemic cardiovascular disease

upin humans1

1 study
  1. Des-gamma-carboxy prothrombin is associated with incident ischemic cardiovascular disease in humans (1.53-fold higher risk per doubling of concentration; 95% CI 1.09–2.13).

    “a doubling of des-γ-carboxy prothrombin concentration was associated with a 1.53 (95% confidence interval, 1.09-2.13; P=0.008) higher risk of incident ischemic cardiovascular disease.”

    HumansInitially free of cardiovascular disease; adjusted for traditional cardiovascular risk factors and measures of vitamin K intake11.0 yearsn = 709

    Vitamin K-Dependent Protein Activity and Incident Ischemic Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis

    Arteriosclerosis, thrombosis, and vascular biology

More on Incident ischemic cardiovascular disease

Latest

Dec 2025: 1Jan 2026: 1Feb 2026: 3Mar 2026: 3Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 08 papers in 12 months